Drug Profile
Research programme: infectious disease vaccines - Tetragenetics
Alternative Names: H5N1 influenza A vaccine - Tetragenetics; Influenza A virus vaccine H5N1 - Tetragenetics; Malaria vaccine - TetrageneticsLatest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Tetragenetics
- Class Subunit vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus infections; Malaria
Most Recent Events
- 13 Sep 2021 Tetragenetics has been acquired by Abcellera
- 28 Jul 2018 No recent reports of development identified for preclinical development in Influenza-A-virus-infections(Prevention) in USA (Parenteral)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Malaria(Prevention) in USA (Parenteral)